Concepedia

Sekhar Duraisamy

SD

Statistics

Publications

15

Citations

1.8K

H-Index

14

Active since

2006

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

University of Vermont

Brigham and Women's Hospital

Boston Children's Hospital

Sekhar Duraisamy is an author at Dana-Farber Cancer Institute specializing in life sciences, oncology, and molecular biology.

Publications per year

2006–2021

15

Publications

15

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

Roel G.W. Verhaak, Pablo Tamayo, Ji-Yeon Yang et al. · Journal of Clinical Investigation · 2012 · 591 citations

, , +17

PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth

Emily Montal, Ruby Dewi, Kavita Bhalla et al. · Molecular Cell · 2015 · 272 citations · Full text

, , +14

The MUC1 and Galectin-3 Oncoproteins Function in a MicroRNA-Dependent Regulatory Loop

Selvi Ramasamy, Sekhar Duraisamy, Sergei F. Barbashov et al. · Molecular Cell · 2007 · 180 citations · Full text

, , +14

Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma

Viswanathan Muthusamy, Sekhar Duraisamy, C. Matthew Bradbury et al. · Cancer Research · 2006 · 168 citations · Full text

, , +17

Interpreting missense variants: comparing computational methods in human disease genes<i>CDKN2A</i>,<i>MLH1</i>,<i>MSH2</i>,<i>MECP2</i>, and tyrosinase (<i>TYR</i>)

Philip A. Chan, Sekhar Duraisamy, Peter J. Miller et al. · Human Mutation · 2007 · 130 citations

, , +17

1–5 of 15